DK0820507T3 - NDF-peptider - Google Patents

NDF-peptider

Info

Publication number
DK0820507T3
DK0820507T3 DK96910630T DK96910630T DK0820507T3 DK 0820507 T3 DK0820507 T3 DK 0820507T3 DK 96910630 T DK96910630 T DK 96910630T DK 96910630 T DK96910630 T DK 96910630T DK 0820507 T3 DK0820507 T3 DK 0820507T3
Authority
DK
Denmark
Prior art keywords
ndf
peptides
heregulins
egf
stimulate
Prior art date
Application number
DK96910630T
Other languages
Danish (da)
English (en)
Inventor
Josette Francoise Cranahan
Shinichi Hara
Hsieng Sen Lu
John Philip Mayer
Stevel Kiyoshi Yoshinaga
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK0820507T3 publication Critical patent/DK0820507T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/4756Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK96910630T 1995-04-06 1996-03-27 NDF-peptider DK0820507T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/417,640 US5670342A (en) 1995-04-06 1995-04-06 NDF peptides

Publications (1)

Publication Number Publication Date
DK0820507T3 true DK0820507T3 (da) 2004-10-04

Family

ID=23654814

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96910630T DK0820507T3 (da) 1995-04-06 1996-03-27 NDF-peptider

Country Status (11)

Country Link
US (4) US5670342A (de)
EP (1) EP0820507B8 (de)
JP (1) JPH11503321A (de)
AT (1) ATE274054T1 (de)
AU (1) AU5377196A (de)
CA (1) CA2216165C (de)
DE (1) DE69633172T2 (de)
DK (1) DK0820507T3 (de)
ES (1) ES2224162T3 (de)
PT (1) PT820507E (de)
WO (1) WO1996031599A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387638B1 (en) * 1997-02-10 2002-05-14 Genentech, Inc. Heregulin variants
US6136558A (en) * 1997-02-10 2000-10-24 Genentech, Inc. Heregulin variants
US20010023241A1 (en) * 1998-02-04 2001-09-20 Sliwkowski Mark X. Use of heregulin as a growth factor
US6017886A (en) * 1998-08-05 2000-01-25 Amgen Inc. Use of NDF peptide as growth factor for sensory epithelium
US6080845A (en) * 1998-08-05 2000-06-27 Amgen Inc. Monoclonal antibody against utricular epithelium
NZ511019A (en) * 1998-11-07 2003-11-28 Genentech Inc An isolated ligand, which is a heregulin polypeptide, to activate HER2 and/or HER3 receptors to induce inner ear hair cell generation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530109A (en) * 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
WO1994028133A1 (en) * 1993-05-21 1994-12-08 Amgen Inc. Recombinant neu differentiation factors

Also Published As

Publication number Publication date
DE69633172D1 (en) 2004-09-23
EP0820507B8 (de) 2005-01-05
ES2224162T3 (es) 2005-03-01
US5686415A (en) 1997-11-11
WO1996031599A1 (en) 1996-10-10
EP0820507B1 (de) 2004-08-18
PT820507E (pt) 2004-11-30
JPH11503321A (ja) 1999-03-26
CA2216165A1 (en) 1996-10-10
AU5377196A (en) 1996-10-23
US5849705A (en) 1998-12-15
ATE274054T1 (de) 2004-09-15
DE69633172T2 (de) 2005-08-11
EP0820507A1 (de) 1998-01-28
US5670342A (en) 1997-09-23
US5929032A (en) 1999-07-27
CA2216165C (en) 2000-08-08

Similar Documents

Publication Publication Date Title
DE69435096D1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
DK0839154T3 (da) Biologiske aktive peptider og præparater samt anvendelse deraf
DK0493480T3 (da) Dehydrodidemnin B
FI961621A0 (fi) Proteiini:farnesyylitranseraasin substituoidut tetra- ja pentapeptidi-inhibiittorit
UA43348C2 (uk) Водна фармацевтична композиція, що включає фактор росту нерва (варіанти) та ліофілізований фармацевтичний склад
ATE216590T1 (de) Arzneimittelformulierungen für il-12
DE69637669D1 (de) Myogene differenzierung menschlicher mesenchymaler stammzellen
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
FI954541L (fi) Keratinosyyttikasvutekijän terapeuttisia käyttöjä
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
EP0956340A4 (de) Proliferation humaner endokriner pankreaszellen in kultur
DK0862452T3 (da) Stabiliserende formulering af NGF
ATE274054T1 (de) Ndf-peptide
NZ311175A (en) Gene preparation comprising a gene incorporated into a biocompatible carrier which preferably contains collagen
AU2766597A (en) Biologically active protein (collagen fragment hf-coll-18/514cf) for inhibiting the growth of tumours and capillary profilerations
EP0812360A4 (de) Menschliche geranyl-geranyl-pyrophosphat synthetase
ES2160969T3 (es) Derivados anticonvulsivos utiles en el tratamiento de la psoriasis.
ATE223427T1 (de) Modifizierte kojibioside analoge
AU3557697A (en) Variants of human ciliary neurotrophic factor (hcntf) with a range of action different from that of the wild-type molecule
EP0879240A4 (de) Menschlicher criptin wachstumsfaktor
IT1251961B (it) Peptidi che rappresentano permutazioni della sequenza del mastoparano
MX9800053A (es) Herbicidas de cis-2,3-expoxicicloalcanol bencilado.
FR2741350B1 (fr) Peptides derives de la proteine oncogene bcr-abl exprimes par des cellules leucemiques et leur utilisation pour la therapie des leucemies humaines
MX9704796A (es) Peptidos novedosos, su preparacion y uso.
UA43383C2 (uk) Штам синьо-зелених водоростей spirulina platensis - продуцент біологічно активних речовин з антибластомними та антимікробними властивостями